Blood Collection, Processing, Management Devices & Consumables Market to Gain Traction to 2023, Says IQ4I in Its Study Available at MarketPublishers.c01 Feb 2017 • by Natalie Aster
LONDON – The market for blood collection, processing, management devices & consumables is poised to be worth USD 35,693 million by 2023-end. The market is expected to be propelled by an upsurge in ageing population and ensuing hike in the incidence rate of chronic illnesses, the introduction of elaborate automated blood sampling and processing devices and the emergence of friendly reimbursement policies. The uptake of needle-free injection devices and RFID technology and opportunities for market expansion in emerging economies are amid the essential opportunities of this marketplace.
However, patient protecting risks owing to chances of infectious disease transmission and dearth of skilled experts in dealing with automated processing devices limit the growth of the global market. The threats for the market encompass rising costs of blood handling devices and austere government regulatory agencies that guide blood processing devices & consumables makers.
Geography-wise, North America takes the lead in the market, followed by the European and the APAC regions. APAC is expected to show the most rapid growth to 2023, offering a slew of growth opportunities and grabbing attention of new investors. The growth in the regional market is due to surging prevalence rates of life-style diseases and government incentives in the establishment of novel technologies and demand for advanced medical services.
Haemonetics Corporation, Abbott Laboratories, Grifols International S.A., Immucor, Inc., Danaher Corporation, Fresenius Kabi, Sysmex Corporation, Terumo Corporation, and ThermoFisher Scientific Corporation are some of the most outstanding polayers in the market.
New IQ4I research report “Blood Collection, Processing, Management Devices & Consumables Global Market - Forecast To 2023” created by IQ4I gives a shrewd view of the marketplace. The report provides granular market segmentation based on application, end-use industry, products and geographic region. It reviews the factors influencing market like opportunities and drivers, threats and limiters. The study canvasses the regulatory environment, reimbursement scenario, technological advances, supply chain analysis, manual versus automated blood collection and processing devices, supply chain analysis, market share analysis, and Porter’s five force analysis. The research study gives insights into the competitive landscape, examines company developments, and includes detailed profiles of the 14 leading players.
More new research studies by IQ4I are available at its page.